2020Â -Â Present | Director, Central Nervous System Metastasis Program, Baptist Health South Florida ‐ Miami Cancer Institute | |
|
||
2018Â -Â Present | Chief, Radiosurgery, Baptist Health South Florida ‐ Miami Cancer Institute | |
|
||
November 2017Â -Â Present | Assistant Professor, Florida International University ‐ Herbert Wertheim College of Medicine | |
|
||
August 2017Â -Â Present | Radiation Oncologist, Baptist Health South Florida ‐ Miami Cancer Institute | |
|
||
2011Â -Â 2011 | Research Assistant, Memorial Sloan Kettering Cancer Center ‐ Department of Radiation Oncology | |
|
||
2009Â -Â 2009 | Research Fellow, Childrens Hospital Los Angeles ‐ Department of Radiology and Department of Hematology/Oncology | |
|
||
2007 - 2008 | Research Fellow, Cincinnati Children’s Hospital Medical Center ‐ Department of Neurology | |
|
||
2005Â -Â 2008 | Professorial Assistantship and Research Assistant, Michigan State University ‐ Michigan State University | |
|
||
2007Â -Â 2007 | Research Assistant, University of Michigan - Ann Arbor ‐ W.K. Kellogg Eye Center | |
|
Disciplines
Grants
2021Â -Â 2032 | Study of LUNG Stereotactic Ablative Adaptive Radiotherapy (LUNG STAAR) |
Baptist Health South Florida, Viewray, Inc. - NCT04917224; 2020-KOT-005 | |
Role: Principal Investigator | |
2020Â -Â 2030 | A Phase II/III Randomized, Open-Label Study of Toca 511, A Retroviral Replicating Vector, Combined with Toca FC with Temozolomide and Radiation Followed by Adjuvant Temozolomide and Toca FC Compared to Temozolomide and Radiation Followed by Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma |
RTOG Foundation Study - NCT04105374; NRG BN006 | |
Role: Radiation Oncology Study Chair | |
2017Â -Â 2030 | A Phase II Randomized Trial of Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients with IDH Mutant, Low to Intermediate Grade Gliomas |
NRG Oncology - NCT03180502 | |
Role: Institutional Principal Investigator | |
2020Â -Â 2028 | A Multicenter Observational Study of GammaTileâ„¢ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms |
GT Medical Technologies, Inc. - NCT04427384; GTM-101 | |
Role: Principal Investigator | |
2017Â -Â 2027 | Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial |
NRG Oncology - NCT03137771 | |
Role: Institutional Principal Investigator | |
2015Â -Â 2027 | Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer |
NRG Oncology - NCT02635009; NRG CC003 | |
Role: Institutional Principal Investigator | |
2020Â -Â 2026 | Dose-Escalated Spine SbRT (DESSRT) Trial for Localized Metastasis to the Spinal Column |
Baptist Health Florida Foundation - NCT04802603; 2020-KOT-003 | |
Role: Principal Investigator | |
2019Â -Â 2026 | Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab |
National Cancer Institute (NCI), NRG Oncology - NCT03811002 | |
Role: Institutional Principal Investigator | |
2014Â -Â 2026 | Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation with Concomitant and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma |
NRG Oncology, National Cancer Institute (NCI), Radiation Therapy Oncology Group - NCT02179086 | |
Role: Institutional Principal Investigator | |
2021Â -Â 2025 | A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on The Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma |
National Cancer Institute (NCI) - NCT04729959; NRG BN010 | |
Role: Radiation Oncology Study Chair | |
2021Â -Â 2024 | A Feasibility Study of Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction for Inoperable Primary or Metastatic Carcinoma (SMART ONE) |
Baptist Health Florida, Viewray, Inc. - NCT04939246 | |
Role: Co-Investigator | |
2020Â -Â 2024 | Randomized Phase II Study of Radiation Therapy Alone Versus Radiation Therapy Plus |
Medtronic - NCT04375891; 2018-KOT-001 | |
Role: Principal Investigator | |
2019Â -Â 2023 | Durvalumab with Thoracic Radiation Therapy without Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (DART) |
Memorial Sloan Kettering Cancer Center - NCT03999710; MSK 19-218 | |
Role: Institutional Principal Investigator | |
2016Â -Â 2023 | LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent with Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure. |
NovoCure, LTD - NCT02973789; EF-24 | |
Role: Institutional Principal Investigator | |
2021Â -Â 2022 | Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery |
Baptist Health Florida, Blue Earth Diagnostics - NCT04689048; 2019-KOT-001 | |
Role: Principal Investigator | |
2019Â -Â 2022 | PROMISE-005: A Phase II Randomized Study Assessing the Efficacy of Stereotactic Body Radiotherapy (SBRT) in Patients with Oligometastatic Breast or Lung Cancer |
Memorial Sloan Kettering Cancer Center - NCT03808337; MSK 18-486 | |
Role: Institutional Principal Investigator | |
2018Â -Â 2022 | A Randomized Trial of Early, Upfront Palliative Radiation Therapy Versus Standard of Care for Patients with Highest Risk Asymptomatic or Minimally Symptomatic Bone Metastases |
Memorial Sloan Kettering Cancer Center - NCT03523351; MSK 18-196 | |
Role: Institutional Principal Investigator | |
2018Â -Â 2022 | A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer |
Memorial Sloan Kettering Cancer Center - NCT03532880; MSK 18-195 | |
Role: Institutional Principal Investigator | |
2018Â -Â 2021 | Phase 1 Trial of Osimertinib with Stereotactic Radiosurgery (SRS) in Patients With Brain Metastases From EGFR Positive Non-Small-Cell Lung Cancer (NSCLC) |
Case Comprehensive Cancer Center - NCT03535363 | |
Role: Institutional Principal Investigator | |
2018Â -Â 2020 | Endoesophageal brachytherapy for patients with esophageal cancer: A balloon repositioning, multichannel radiation applicator for optimizing treatment delivery |
Case Comprehensive Cancer Center - NCT03335813; CASE5217 | |
Role: Co-Investigator |
Professional Service and Affiliations
2020 - Present | Member, Radiation Safety Committee, Baptist Health South Florida | 2020 - Present | Committee Moderator, Committee Member, Viewray Inc. Research Consortium (CNS) | 2019 - Present | Co-organizer. Glioblastoma / Brain Metastasis Clinical Working Group, National Cancer Institute | 2018 - Present | Course Director, Annual Miami Brain Symposium | 2017 - Present | Member. Data Safety and Monitoring Committee, Miami Cancer Institute, Baptist Health South Florida | 2017 - 2022 | Co-Chair. Committee Member. CNS Committee, Proton Collaborative Group | 2021 - 2021 | Course Director, Miami Radiosurgery Conference | 2019 - 2021 | Course Director, Introduction of Gamma Knife Radiosurgery Training Course | 2010 - 2011 | Public Relations and Editor. Medical Student Research Journal, Michigan State University College of Human Medicine, East Lansing, MI | Advisory Board Member, Brain Cancer Faculty | Editorial Board, Frontiers in Oncology | Editorial Contributor, PracticeUpdate’s Center of Excellence, Elsevier, Inc. | Associate Editor, Radiation Oncology |
Honors and Awards
- 2017 Cleveland Clinic Educational Foundation Excellence in Teaching Award
- 2016 Cleveland Clinic Educational Foundation Excellence in Teaching Award
- 2015 ASTRO Annual Meeting Resident Abstract Award (2nd place clinical)
- 2014-2015 The Cleveland Clinic Jerrold P. Saxton Award for Clinical Excellence
- 2011 Inducted into the Alpha Omega Alpha Honors Medical Society
- 2011, 2012 Wilbur C. Wright Memorial Scholarship
- 2008-2011 The Bernard F. and Melissa Anne Bailey Family Scholarship Award
- 2010 Graduate Student Research Enhancement Award
- 2010 Helen and Verne Beilfuss Memorial Research Award for Cancer-related Research
- 2008 The Midland County Medical Society Alliance Health Careers Scholarship Award
- 2008 Stephen D. Redman M.D. Memorial Scholarship Award
- 2008 MSU Board of Trustee’s Award for highest cumulative grade point, 4.0
- 2008 MSU Department of Physiology Award for Academic Excellence
- 2005-2008 MSU College of Natural Science Dean’s Honor List
- 2005 Alumni Distinguished Scholars Semi-Finalist
- 2005 National Merit Finalist
- 2005 Covenant HealthCare Foundation Scholarship Award
- 2004 Bausch & Lomb Honorary Science Award, University of Rochester
July 2012Â -Â June 2017 | Residency Program - Radiation Oncology, Cleveland Clinic Foundation | |
|
||
August 2008Â -Â May 2012 | Doctor of Medicine, M.D., Michigan State University ‐ College of Human Medicine | |
|
||
August 2005Â -Â May 2008 | Medical Scholars Program, Michigan State University ‐ College of Human Medicine | |
|
||
August 2005Â -Â May 2008 | Physiology, B.S., Michigan State University ‐ Honors College | |
|